44 related articles for article (PubMed ID: 22938159)
1. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
[TBL] [Abstract][Full Text] [Related]
2. Repeated human leukocyte antigens eplets, importance of typing the partner.
Dos Reis Ferreira C; da Silva Fernandes VM; Tafulo SCR; Cerqueira A; Rocha ACB; Nunes ATPM; Ferreira IPCN; Santos MJC; Pinho ATMT; Tavares IC; Guerra MMBB; Norton SMMS
Transpl Immunol; 2024 Jun; 84():102049. PubMed ID: 38729449
[TBL] [Abstract][Full Text] [Related]
3. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies.
García-Jiménez S; Paz-Artal E; Trujillo H; Polanco N; Castro MJ; Del Rey MJ; Alfocea Á; Morales E; González E; Andrés A; Mancebo E
HLA; 2024 Jun; 103(6):e15572. PubMed ID: 38923242
[TBL] [Abstract][Full Text] [Related]
4. Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.
Viglietti D; Loupy A; Vernerey D; Bentlejewski C; Gosset C; Aubert O; Duong van Huyen JP; Jouven X; Legendre C; Glotz D; Zeevi A; Lefaucheur C
J Am Soc Nephrol; 2017 Feb; 28(2):702-715. PubMed ID: 27493255
[TBL] [Abstract][Full Text] [Related]
5. Exploring the immunological relevance of pre-transplant donor-specific antibody in intestinal transplantation, with special consideration to the liver.
McArdle R; Cope R; Chaudhry A; Sharkey L; Peacock S
Int J Immunogenet; 2024 Apr; ():. PubMed ID: 38637869
[TBL] [Abstract][Full Text] [Related]
6. First World Consensus Conference on pancreas transplantation: Part II - recommendations.
Boggi U; Vistoli F; Andres A; Arbogast HP; Badet L; Baronti W; Bartlett ST; Benedetti E; Branchereau J; Burke GW; Buron F; Caldara R; Cardillo M; Casanova D; Cipriani F; Cooper M; Cupisti A; Davide J; Drachenberg C; de Koning EJP; Ettorre GM; Fernandez Cruz L; Fridell JA; Friend PJ; Furian L; Gaber OA; Gruessner AC; Gruessner RWG; Gunton JE; Han DJ; Iacopi S; Kauffmann EF; Kaufman D; Kenmochi T; Khambalia HA; Lai Q; Langer RM; Maffi P; Marselli L; Menichetti F; Miccoli M; Mittal S; Morelon E; Napoli N; Neri F; Oberholzer J; Odorico JS; Öllinger R; Oniscu G; Orlando G; Ortenzi M; Perosa M; Perrone VG; Pleass H; Redfield RR; Ricci C; Rigotti P; Paul Robertson R; Ross LF; Rossi M; Saudek F; Scalea JR; Schenker P; Secchi A; Socci C; Sousa Silva D; Squifflet JP; Stock PG; Stratta RJ; Terrenzio C; Uva P; Watson CJE; White SA; Marchetti P; Kandaswamy R; Berney T
Am J Transplant; 2021 Sep; 21 Suppl 3(Suppl 3):17-59. PubMed ID: 34245223
[TBL] [Abstract][Full Text] [Related]
7. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
Everly MJ
Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
[TBL] [Abstract][Full Text] [Related]
8. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
Cheng EY; Kaneku H; Farmer DG
Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
Cooper JE; Gralla J; Chan L; Wiseman AC
Clin Transpl; 2011; ():359-64. PubMed ID: 22755431
[TBL] [Abstract][Full Text] [Related]
10. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
11. Long-term post transplant alloantibody monitoring: a single center experience.
Ntokou IS; Boletis JN; Apostolaki M; Vrani V; Zavos G; Kostakis A; Iniotaki A
Clin Transpl; 2011; ():341-50. PubMed ID: 22755429
[TBL] [Abstract][Full Text] [Related]
12. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
14. Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience.
Mujtaba MA; Fridell JA; Higgins N; Sharfuddin AA; Yaqub MS; Kandula P; Chen J; Mishler DP; Lobashevsky A; Book B; Powelson J; Taber TE
Clin Transplant; 2012; 26(5):E492-9. PubMed ID: 22938159
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
